LabShares handles your administrative tasks so you can focus on #science! Book a tour of our beautiful space to join us today and start innovating tomorrow. https://t.co/XZpSiH1u8g
LabShares’ shared laboratory model is essential to support early-stage companies, which are the life blood of the biotech and life sciences industry https://t.co/13iRS83ZMj
Extend Biosciences announces positive data from Phase 1 trial of EXT608 for the treatment of Hypoparathyroidism. The initial pharmacokinetic profile is consistent with a once-weekly dosing regimen. https://t.co/wDpGFFZ05Z
If your biotech or life science company is interested in bench vacancies in our newly renovated BL2 lab with a comprehensive set of shared equipment like flow cytometry, plate readers, QT PCR, HPLC and more, please contact us at https://t.co/FAjzGKAyAA
TRIANA Biomedicines, a leading biopharma co. focused on building a target-first and rational molecular glue discovery platform for inactivating difficult to address disease targets, announced the addition of Robert A. Copeland, PhD, & Adrian M. Senderowicz, MD to its board (SAB).
To biotech startups who are interested to win 1 full year of lab access and office space in our fully equipped and newly renovated BL2 lab in Newton, MA (and more), you may submit your pitch deck & apply here - https://t.co/Mzo4RbFt5f. Deadline is on Sep 15!
We’re excited to announce the return of our Launch@LabShares pitch competition! The winner will be awarded a free year of lab and office space. Click to learn about our recent expansion as well as the pitch competition.
https://t.co/gnT4UzTOcJ
On Thursday, MassBio President and COO @KendalleOC spoke with entrepreneurs at @LabShares new space in Newton. This type of facility is essential for the growth of the #lifesciences ecosystem, giving emerging companies a place to collaborate and focus on their science.